PNPolina A. Novikova

Polina A. Novikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Polina A. Novikova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cellular senescence in cartilage and bone tissue aging: role in disease development and therapeutic potential

    by Natalia G. Plekhova, Polina A. Novikova, Nikolay V. Tsvetov, Плехова Наталья Геннадьевна, Цветов Николай Владимирович

    Cellular senescence induced by various types of stress leads to irreversible cell cycle arrest and alterations in gene expression, metabolism, chromatin organization, and activation of anti-apoptotic signaling pathways. This process results in the formation of a pro-inflammatory secretome, known as the senescence-associated secretory phenotype, which triggers chronic sterile inflammation (inflammaging). This review summarizes current evidence on the role of cellular senescence in age-related changes and diseases of the joints and skeletal system, as well as potential therapeutic strategies. Based on an articles search in the Google Scholar, PubMed (MEDLINE), Scopus, and Web of Science databases using specific keywords and their combinations and the AMSTAR 2 methodology, this review presents the role of cellular senescence in age-related changes and diseases of the joints and skeletal system. Data are presented demonstrating the presence of senescent cells with a senescence-associated secretory phenotype expressing the p16Ink4a protein in the microenvironment of cartilage and bone tissue. It was demonstrated that with advancing age, stem and progenitor cells, osteoblasts, osteocytes, and chondrocytes express senescence markers and acquire characteristic aging-associated traits such as genomic instability, telomere shortening, epigenetic modifications, proteostasis loss, and mitochondrial dysfunction. It has been demonstrated that cellular senescence and the development of the secretory phenotype are causally linked to chronic inflammation and contribute to the development of osteoporosis and osteoarthritis. A new strategy for the treatment of osteoporosis and osteoarthritis—senotherapy—is presented, in which the therapeutic targets are senescent cells (senolytics) or various mechanisms responsible for their survival and transformation into the senescence-associated secretory phenotype (senomorphics). Evidence shows that advances in senescence research over the past decade have laid the groundwork for novel therapeutic approaches targeting joint and bone diseases. Further investigation of the endocrine activity of senescence-associated secretory phenotype cartilage and bone cells is needed to provide the basis for understanding interactions among different systems of the aging organism and for developing strategies for the simultaneous treatment of age-related disorders.


  • Magnesium alloy composite coatings: In vitro study of cytotoxicity, adhesion, cellular structure and function

    by Natalya G. Plekhova, Polina A. Novikova, Ivan N. Chernenko, Aleksandra K. Stepanyugina, Olga V. Shevchenko, Valeria S. Marchenko, Andrey S. Gnedenkov, Sergey L. Sinebryukhov, Sergey V. Gnedenkov, Valentin B. Shumatov

    Background — Synthesis of novel grafts and biomaterial substitutes for bone reconstruction and study of their properties confirmed that the ideal material for this purpose has not yet been developed. Further efforts are needed to create contemporary biocompatible implants. It was shown that degradable biomaterials such as magnesium (Mg) alloys have potential clinical applications for bone reconstruction. However, poor resistance of Mg alloys to corrosion is a serious obstacle to their clinical use. This study aimed at investigating the biocompatibility and potential application of novel multifunctional self-healing coatings on Mg alloys to ensure stable performance of Mg implants in clinical settings. Methods — We studied a magnesium-based Mg MA8 alloy samples both with and without coatings containing hydroxyapatite, Ca10(PO4)6(OH)2. The latter were obtained by plasma electrolytic oxidation (PEO) and included cerium (Ce) and polycaprolactone (PCL). Toxicokinetic properties, cell adhesion, cytocompatibility and cellular enzyme activity were assessed after contact with the composite coating covering Mg. Results — The highest numbers of viable fibroblasts and tumor cells from the HeLa cell culture were observed after contact with Mg+PEO. Moderate cytotoxicity was found for the hydroxyapatite hybrid coating including cerium oxide (CeO2) and PCL. The variability of the parameters for these samples was similar to the variability of the parameters for intact cells and cells in contact with titanium, which showed minimal cytotoxic effects. Compared with copper, which had high cytotoxic activity, the values for the studied samples were significantly lower. After 30 minutes of exposure to Mg, a large number of agglomerates of rounded cells with numerous folded and filiform pseudopodia were observed. Cells on Mg+PEO surfaces were less aggregated and predominantly had fibrillar pseudopodia, also known as filopodia. Numerous rounded folds were observed on the surface of the Mg+PEO+CeO2+PCL hybrid coating, and cell groups were found in close contact resembling a syncytium. The number of stimulated cells on Mg+PEO decreased over time compared to the PEO-based hybrid coating on Mg with CeO2+PCL. Conclusion — The results of this study imply that the bioactive PEO composite coating with PCL and CeO2 modifies the Mg alloy surface by providing porosity that promotes strong cell attachment. These findings provide an alternative approach to develop multifunctional Mg-based implants and expand the biomedical applications of these materials. The data support the need for further investigation of the osteoinductive properties of coatings on biodegradable Mg implants.


  • MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM

    by Plekhova N.G., Novikova P.A., Shumatov V.B.

    Mesenchymal stem/stromal cells (MSCs) and fibroblasts are present in normal tissues to maintain tissue homeostasis and share a number of common features such as spindle-shaped morphology, localization in connective tissue, and multipotency. During inflammation, fibroblasts and MSCs non-specifically respond to injury via two mechanisms of action: immunomodulation and regeneration. Upon tissue injury, MSCs are activated, proliferate, and differentiate. With age and, in particular, in degenerative diseases of the musculoskeletal system (diseases of the muscles, joints and bones), the regenerative capacity of MSCs is lost or redirected to the production of other non-functional cell types such as adipocytes and fibroblasts, which provide much of the structural framework of almost all tissue types. By performing an immunosuppressive role, MSCs and fibroblasts contribute to the normal resolution of inflammation, which is a prerequisite for successful tissue repair. The aim of the review is to provide an understanding of the common and opposite properties of MSCs and FB from the standpoint of age-related changes in the musculoskeletal system in order to develop approaches to their complementary assistance for successful tissue regeneration. The key features of aging MSC and fibroblast are presented, and it is indicated that additional studies are needed on the cellular mechanisms that together generate dysfunctions of individual niches of terminal differentiated cells during aging. The currently existing technologies of cell therapy for the musculoskeletal system diseases involving MSCs and fibroblasts are presented.

  • Open Access

    Cellular mechanisms of age-dependent bone remodeling

    by Natalya G. Plekhova, Polina A. Krivolutskaya, Ivan N. Chernenko, Плехова Наталья Геннадьевна

    The structural integrity of the skeleton is ensured by the constant remodeling of bone tissue, which is based on the functioning and interaction of osteolytic cells (osteoclasts) and bone tissue forming cells (osteoblasts/osteocytes). Despite the general understanding that the degree of mineralization of the bone matrix determines the fragility of the skeleton, there is currently insufficient information about its age-related changes associated with the functioning of these cells. The purpose of the review is to evaluate existing data on age-related bone changes associated with the functional state of mesenchymal stem cells, osteoblasts/osteocytes and osteoclasts. Inclusion criteria: randomized or non-randomized controlled studies examining age-related bone change. A search for studies in the field of bone tissue condition was carried out in electronic scientific databases Google Scholar, Medline, PubMed, Scopus, Web of Science and Cochrane Library by keywords and their combinations using the AMSTAR 2 program. The selection of publications (59 out of 680 included) was carried out randomly, after which three authors independently assessed their methodological quality. The main pathogenetic mechanism involved in bone loss with age is a decrease in the formation of osteoblasts with impairment of their ability to osteogenic differentiation. Osteocytes in old age are subject to excessive and prolonged stress, which causes unbalanced autophagy and apoptosis, which leads to changes in their ability to deposit and mineralize extracellular organic matrix. With age, accelerated osteoclastogenesis occurs, mediated by osteoblasts, which leads to increased expression of certain receptors at the level of bone stromal cells and osteoblasts. The presented literature data demonstrate convincing evidence that an increase in bone resorption due to complex metabolic processes with age occurs against the background of an increase in the number and activity of osteoclasts, apoptosis of osteoblasts with a decrease in their metabolic activity, as well as a redistribution of osteogenic differentiation of mesenchymal stem cells towards adipocytes. The results presented in the review can be used as a basis for developing diagnostic criteria for identifying senile osteoporosis and the risk of fractures.